4.3 Article

Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Increased Prevalence of Fractures in Congenital Adrenal Hyperplasia: A Swedish Population-based National Cohort Study

Henrik Falhammar et al.

Summary: Patients with congenital adrenal hyperplasia (CAH) have an increased prevalence of fractures, especially those associated with osteoporosis. This highlights the need for regular assessment of fracture risk and optimization of treatment.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Review Endocrinology & Metabolism

Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management

Hedi L. Claahsen-van der Grinten et al.

Summary: Congenital adrenal hyperplasia is a group of autosomal recessive disorders affecting cortisol biosynthesis, with the most common form caused by steroid 21-hydroxylase deficiency due to mutations in CYP21A2. Recent developments include advancements in understanding steroidogenic pathways, improvements in diagnostic measurements, and exploration of alternative medications and treatments for CAH patients.

ENDOCRINE REVIEWS (2022)

Review Endocrinology & Metabolism

Components of Metabolic Syndrome in Youth With Classical Congenital Adrenal Hyperplasia

Mimi S. Kim et al.

Summary: Classical CAH patients have a higher prevalence of cardiovascular metabolic risk factors, although the complete metabolic syndrome is relatively rare in children and adolescents. Understanding the traditional and non-traditional risk factors in CAH patients can guide treatment options and prevent the onset of metabolic syndrome in adulthood.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Endocrinology & Metabolism

Epidemiology and Long-Term Adverse Outcomes in Korean Patients with Congenital Adrenal Hyperplasia: A Nationwide Study

Jung Hee Kim et al.

Summary: Our study reveals a recent decline in the incidence of CAH in Korea. CAH patients are at higher risk for cardiovascular, metabolic, skeletal, and psychiatric disorders. Lifelong management of comorbidity risk is essential for treating CAH patients.

ENDOCRINOLOGY AND METABOLISM (2022)

Article Endocrinology & Metabolism

Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia

Ahmed Torky et al.

Summary: Patients with CAH have a higher prevalence of obesity, hypertension, insulin resistance, fasting hyperglycemia, and dyslipidemia during childhood and adulthood compared to the general US population, indicating an early onset of metabolic morbidity in this population. Treatment-related and familial factors play a role in the development of these metabolic conditions.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Endocrinology & Metabolism

Reproductive and Perinatal Outcomes in Women with Congenital Adrenal Hyperplasia: A Population-based Cohort Study

Angelica Linden Hirschberg et al.

Summary: The study found that women with CAH have lower birth rates, higher rates of gestational diabetes and cesarean section, but comparable perinatal outcomes with controls.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Biochemistry & Molecular Biology

Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Luisa Paizoni et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2020)

Review Endocrinology & Metabolism

Bone Mineral Density in Adults With Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis

Swetha Rangaswamaiah et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Review Medicine, General & Internal

Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

Deborah P. Merke et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Prevalence and management of hypercholesterolemia in France, the Esteban observational study

Jacques Blacher et al.

MEDICINE (2020)

Review Biochemistry & Molecular Biology

The Role of International Databases in Understanding the Aetiology and Consequences of Differences/Disorders of Sex Development

Salma Rashid Ali et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Endocrinology & Metabolism

Cardiovascular and Metabolic Outcomes in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis

Shrikant Tamhane et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)

Article Endocrinology & Metabolism

Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline

Phyllis W. Speiser et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)

Article Pharmacology & Pharmacy

Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-based Multi -database Study

Jetty A. Overbeek et al.

CLINICAL THERAPEUTICS (2017)

Article Endocrinology & Metabolism

Cardiovascular Abnormalities and Impaired Exercise Performance in Adolescents With Congenital Adrenal Hyperplasia

Alberto M. Marra et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)

Article Endocrinology & Metabolism

Increased Cardiovascular and Metabolic Morbidity in Patients With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study

Henrik Falhammar et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)

Article Endocrinology & Metabolism

Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Diala El-Maouche et al.

CLINICAL ENDOCRINOLOGY (2015)

Editorial Material Endocrinology & Metabolism

CaHASE: a Specialist Society Led Academic Collaboration to improve the management of CAH

Richard J. M. Ross

CLINICAL ENDOCRINOLOGY (2014)

Article Endocrinology & Metabolism

The Effect of Metformin on Androgen Production in Diabetic Women with Non-classic Congenital Adrenal Hyperplasia

R. Krysiak et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2014)

Article Endocrinology & Metabolism

Increased Psychiatric Morbidity in Men With Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

Henrik Falhammar et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)

Review Endocrinology & Metabolism

Treatment and health outcomes in adults with congenital adrenal hyperplasia

Thang S. Han et al.

NATURE REVIEWS ENDOCRINOLOGY (2014)

Article Endocrinology & Metabolism

The Effect of Simvastatin Treatment on Plasma Steroid Levels in Females with Non-classic Congenital Adrenal Hyperplasia

R. Krysiak et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2013)

Article Endocrinology & Metabolism

Clinical Characteristics of a Cohort of 244 Patients with Congenital Adrenal Hyperplasia

Gabriela P. Finkielstain et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)

Review Endocrinology & Metabolism

Clinical outcomes in the management of congenital adrenal hyperplasia

Henrik Falhammar et al.

ENDOCRINE (2012)

Article Endocrinology & Metabolism

Health Status of Adults with Congenital Adrenal Hyperplasia: A Cohort Study of 203 Patients

Wiebke Arlt et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)

Article Endocrinology & Metabolism

Fractures and bone mineral density in adult women with 21-hydroxylase deficiency

Henrik Falhammar et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)

Article Endocrinology & Metabolism

Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Henrik Falhammar et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)

Article Medicine, General & Internal

Global burden of hypertension: analysis of worldwide data

PM Kearney et al.

LANCET (2005)